Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1969 1
1970 1
1972 2
1975 1
1976 2
1978 1
1991 1
2001 1
2008 1
2009 1
2010 2
2011 2
2012 1
2013 2
2014 4
2015 3
2016 2
2017 6
2018 2
2019 1
2020 1
2021 5
2022 6
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment.
Genge A, Pattee GL, Sobue G, Aoki M, Yoshino H, Couratier P, Lunetta C, Petri S, Selness D, Bidani S, Hirai M, Sakata T, Salah A, Apple S, Wamil A, Kalin A, Jackson CE. Genge A, et al. Among authors: kalin a. Muscle Nerve. 2023 Feb;67(2):124-129. doi: 10.1002/mus.27768. Epub 2022 Dec 28. Muscle Nerve. 2023. PMID: 36504406 Free PMC article. Clinical Trial.
Cardiac arrhythmia: a simple conceptual framework.
Kalin A, Usher-Smith J, Jones VJ, Huang CL, Sabir IN. Kalin A, et al. Trends Cardiovasc Med. 2010 Apr;20(3):103-7. doi: 10.1016/j.tcm.2010.09.003. Trends Cardiovasc Med. 2010. PMID: 21130954
A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies.
Kalin A, Medina-Paraiso E, Ishizaki K, Kim A, Zhang Y, Saita T, Wasaki M. Kalin A, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Oct;18(sup1):71-79. doi: 10.1080/21678421.2017.1362440. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28872919 Clinical Trial.
Extended Ladder-Type Benzo[k]tetraphene-Derived Oligomers.
Lee J, Li H, Kalin AJ, Yuan T, Wang C, Olson T, Li H, Fang L. Lee J, et al. Among authors: kalin aj. Angew Chem Int Ed Engl. 2017 Oct 23;56(44):13727-13731. doi: 10.1002/anie.201707595. Epub 2017 Oct 2. Angew Chem Int Ed Engl. 2017. PMID: 28887849
53 results